Find investors who align with your industry, stage, and vision. Unlock Georg von Schwarzkopf’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayGeorg von Schwarzkopf is a Venture Capital, Private Equity Firm, Investor based in Germany with a diverse investment portfolio that includes companies such as Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation, Breath Therapeutics, Roche Glycart, Innate Pharma, Inova Labs, Moximed, Nightbalance, Eargo, Inari Medical, STAT-Dx, VerzuimVitaal, Ascendis Pharma, SANIFIT, BG Medicine, Prosonix, Nyxoah, Draupnir Bio, Axonics Modulation Technologies, Levicept, Big Health, Calypso Biotech, NIZO, Chroma Therapeutics, Pieris AG, LUMICKS, Ablative Solutions, Symphogen, MTM Laboratories, Definiens, Fysius Rugexperts, Agendia, Vesper Medical, Galapagos, Lumeon, Pharmaline, Volta Medical, Amphista Therapeutics, Withings, Novicare, ProFibrix, Ablynx, Conatus Pharmaceuticals, Zetacom, BionX™ Medical Technologies, Acacia Pharma, CVRx, Lava Therapeutics, Stepping Stones Home & Care, Evotec, Vapotherm, FlowCardia, FIRE1. Over time, Georg von Schwarzkopf has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Georg von Schwarzkopf is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Enterprise, Consumer Electronics, Wellness, Medical Testing, Apps, Life Science, Artificial Intelligence (AI), Marketplace, Medical Device, Software, Healthcare, Biotechnology, Enterprise Applications, Health and Hospital Services, FinTech, Health IT, Audio, Health Diagnostics, Digital Health, Medical, SaaS, Compliance, Biopharma may find it worthwhile to explore potential connections with Georg von Schwarzkopf, as their portfolio suggests a familiarity and interest in this area.
Understanding Georg von Schwarzkopf’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today